Bristol-Myers to pay $19.5M over improper marketing of Abilify

California officials alleged the company promoted the anti-psychotic drug for unapproved uses on children, elderly patients with dementia Bristol-Myers Squibb Co. will pay $19.5 million to settle allegations that it promoted the anti-psychotic drug Abilify for unapproved uses and misled doctors about its dangers, it was announced Thursday. California Attorney General Kamala Harris announced the [...]